Use of global hemostatic markers for risk stratification and personalized treatment of coronary artery disease
Coronary artery disease has been linked to a hypercoagulable state of the blood, and the use of global hemostatic assays such as thromboelastography, thrombin generation or the overall hemostatic assay may allow for prediction of adverse events in these patients as well as targeted, individualized treatment. by Dr C. Reddel, Dr J. Curnow and Professor […]
